NPI: 1700848819 · NASHUA, NH 03060 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 04/04/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 04/04/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 14,782 | $119K |
| 2019 | 9,330 | $118K |
| 2020 | 15,015 | $197K |
| 2021 | 22,607 | $254K |
| 2022 | 14,869 | $156K |
| 2023 | 778 | $519.78 |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 28,833 | 1,122 | $837K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 21,941 | 702 | $6K |
| J1756 | Injection, iron sucrose, 1 mg | 5,207 | 623 | $411.66 |
| 83970 | 862 | 365 | $54.64 | |
| A4657 | Syringe, with or without needle, each | 4,342 | 983 | $27.46 |
| J1270 | Injection, doxercalciferol, 1 mcg | 10,724 | 388 | $12.50 |
| 83540 | 660 | 279 | $9.54 | |
| 85041 | 1,571 | 650 | $7.83 | |
| 82728 | 711 | 302 | $6.31 | |
| 85048 | 1,561 | 649 | $5.82 | |
| 83550 | 683 | 279 | $5.35 | |
| 90674 | 30 | 12 | $3.20 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 153 | 55 | $0.00 |
| 82108 | 63 | 25 | $0.00 | |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 40 | 24 | $0.00 |